“Lily is taking these steps to make it easier to access their insulin and help Americans who may struggle with a complex health care system that can prevent them from receiving affordable insulin,” the group said in a statement with its headquarters in Indianapolis. in the central United States.
It is one of Joe Biden’s favorite projects. In a country with more than 30 million diabetics and seven million in need of treatment, this is a matter of public health and social justice, and therefore a political issue, reports Guillaume Naudin, RFI’s correspondent in Vienna.
Last summer, the Inflation Reduction Act capped out-of-pocket expenses for seniors covered by public health insurance at $35 a month. Every time since then, even in the last State of the Union address, the President has called on drug gangs to follow suit. It should be noted that some products are very expensive, sometimes as much as $1,000 a month for those who do not benefit from price control.
Joseph Biden celebrates the decision. In the constitution, he called for the most important decision and invited the competition to a match. “It costs less than $10 to make insulin, but Americans are sometimes forced to pay more than $300 for it. It’s not fair,” he said, urging other pharmaceutical companies to “follow” this example.
A price reduction of 70
This also makes Eli Lilly, which has plans to compare things with other laboratories, much less money and thus win market shares so, obviously, it is quite juicy to be able to afford these record discount rates. .
Specifically, the company will reduce the price of its best-selling insulin, Humalog and Humulin, by 70% starting in the fourth quarter of 2023. At the same time, Eli Lilly will reduce the price of the generic insulin Insulin Lispro to $25. bowl to May 1 from the current price of $82. The company will also limit maximum out-of-pocket costs for healthy and uninsured patients to $35 per month, in line with US government proposals.
Eli Lilly came under fire in November after a tweet from a Twitter account that was named, but also promised, fake, free insulin. The episode reignited the debate over the price of the drug.
Insulin prices in the United States have skyrocketed in recent decades, eight times more than prices in 32 comparable high-income countries, according to a 2020 study by the Rand Corporation.
Diabetes is divided into two types. An estimated nineteen million people have type 2 diabetes, a chronic condition in which the pancreas does not produce enough insulin, a hormone that regulates blood sugar levels.
Most people affected by diabetes have type 2, which is associated with great pain and other lifestyle issues and occurs in adults and more so in children.
All type 1 diabetics need insulin to survive, and access is almost guaranteed.
According to the World Health Organization (WHO), about 63 million people have type 2 diabetes and also need the hormone, but only about half can access it.